David Farnell

6PUBLICATIONS
36CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 27, 2025
A Deep Learning Framework for Classification of Neuroendocrine Neoplasm Whole Slide Images.

Amir Hadjifaradji, Michael Diaz-Stewart, Jenny Chu

|Jul 05, 2022
Incidental alpha-1-antitrypsin deficiency found in post-transplant liver allografts: Report of two cases.

Jonathan Lee, Eric M Yoshida, Andre Mattman

|Aug 02, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.

Pauline Krämer, Aline Talhouk, Mary Anne Brett

|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.

Jennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier

|Dec 18, 2019
The coming 15 years in gynaecological pathology: digitisation, artificial intelligence, and new technologies.

David A Farnell, David Huntsman, Ali Bashashati

Pageof 1